9 articles
Kimberly-Clark is preparing asset concessions to secure EU antitrust approval for its $40 billion acquisition of Kenvue, following conditional clearances in Australia and South Africa. The deal combin
Kimberly-Clark has requested EU regulatory approval for its proposed $40 billion acquisition of Kenvue. The deal, expected to close in late 2026, aims to combine portfolios for roughly $32 billion in
Kenvue missed Q2 earnings as inflation and tariffs squeezed margins, pending a $40 billion acquisition by Kimberly-Clark closing in late 2026. Sales rose 3% despite cost pressures affecting gross prof
Arbex, a joint venture backed by Suzano and Kimberly-Clark, aims to raise its global tissue market share to over 35% through annual investments of up to $120 million. The venture seeks to optimize cos
Multinational firms in India are deploying AI to automate corporate functions and accelerate drug launches. Companies like Novo Nordisk and Kimberly-Clark utilize the technology for regulatory support
Britain's competition regulator approved the $3.4 billion joint venture between pulp producer Suzano and Kimberly-Clark without further investigation.
Kimberly-Clark's UK plant will utilize green hydrogen following a £55 million investment, cutting natural gas demand by 50% and reducing 18,300 metric tons of CO2 annually. This project is among the f
Brazil's Suzano is expected to receive unconditional EU antitrust approval for its $3.4 billion joint venture with Kimberly-Clark. The deal grants Suzano a 51% stake in Kimberly-Clark's international
Kimberly-Clark projects up to $170 million in extra costs if oil prices stay around $100 per barrel, citing input inflation risks similar to Procter & Gamble. Despite these warnings, the company poste
ChemBrief